Acorda Therapeutics IncのEV / EBITDA
Acorda Therapeutics IncのEV / EBITDAは何ですか。
Acorda Therapeutics IncのEV / EBITDAはN/Aです。
EV / EBITDAの定義は何ですか。
EV / EBITDA は、企業価値をEBITDA（利息、税金、減価償却費および償却費を控除する前の利益）で割ったものですです。これは、株価がどれほど高価で、P / E比よりも頻繁に企業をお互いを比較するために使用されます。これは、投資家が会社のキャッシュフローの利益のために支払う価格を測定します。
Price to earnings ratios are impacted by a company's choice of capital structure - companies which raise money via debt will have lower P/Es (and therefore look cheaper) than companies that raise an equivalent amount of money by issuing shares, even though the two companies might have equivalent enterprise values. A sample case is when a company with debt were to raise money by issuing shares of stock, and then used the money to pay off the debt, this company's P/E ratio would shoot up because of the increased number of shares - although nothing about the fundamental value of the business has changed. EV / EBITDA is unaffected by capital structure as enterprise value includes the value of debt, and EBITDA is available to all investors (debt and equity) as it excludes interest payments on that debt. It is ideal for analysts and potential investors looking to compare companies within the same industry.
NASDAQのセクタHealth CareにおけるEV / EBITDAの企業と比べるAcorda Therapeutics Inc
Acorda Therapeutics Incは何をしますか。
acorda therapeutics is a publicly traded (nasdaq: acor) biotechnology company whose mission is to develop therapies that restore neurological function and improve the lives of people with neurological disorders. we started our company in 1995 as a network of scientists, physicians and business people with a common belief that sharing ideas and information could lead to innovative medical advances for people with neurological disorders. we have since evolved into a commercial-stage biotechnology company, successfully developing and commercializing important therapies that advance the care of people affected by neurological conditions. we achieve our goals by: • investing in research and development • collaborating closely with the patient, medical and scientific communities • retaining employees with compassion and commitment acorda has been voted one of the best companies to work for in new york for the past five years in a row, as a result of our dynamic environment, strong corporate
Acorda Therapeutics Incと類似のev / ebitda
- Jia YaoのEV / EBITDAはN/Aです。
- CLS USAのEV / EBITDAはN/Aです。
- Overseas Chinese Town (Asia)のEV / EBITDAはN/Aです。
- Starr Peak ExplorationのEV / EBITDAはN/Aです。
- Good Friend InternationalのEV / EBITDAはN/Aです。
- DoorDash IncのEV / EBITDAはN/Aです。
- Acorda Therapeutics IncのEV / EBITDAはN/Aです。
- Inspur InternationalのEV / EBITDAはN/Aです。
- Setubandhan InfrastructureのEV / EBITDAはN/Aです。
- Avalon WorksのEV / EBITDAはN/Aです。
- Galileo Mining LtdのEV / EBITDAはN/Aです。
- Trine AcquisitionのEV / EBITDAはN/Aです。
- Dreadnought ResourのEV / EBITDAはN/Aです。